Sign in to view content

Interim 12-Month Results from PALADIN in Diabetic Macular Patients Receiving ILUVIEN: Analysis of the Prior Dexamethasone Cohort

Daniel F. Kiernan, MD, FACS

Video
Published 2019

Related

Best Corrected Visual Acuity at 36 Months in Study of FAi Insert for NIPU
Sumit Sharma, MD, FASRS
Annual Meeting Talks
2019
Time to Retinal Fluid Control With Faricimab vs Aflibercept in Patients With DME in the Phase 3 YOSEMITE/RHINE Trials
Aleksandra V. Rachitskaya, MD, FASRS
Annual Meeting Talks
2023
Intravitreal Gene Therapy for Diabetic Macular Edema With ADVM-022: First-Time Data Presentation of Prospective, Randomized Phase 2 INFINITY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more